Review article · 14 Mar 2025
Mini reviewPublished 2016
Plants as Bioreactors- A Review
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Currently available systems for the commercial production of recombinant subunit vaccines include bacteria, yeasts, insects and mammalian cell cultures. Each of these systems has specific benefits, but overall, their application is limited by insufficient scalability, cost, safety and target integrity. Plant-based production platforms remains attractive as an alternative due to high scalability, cost-effectiveness and greater safety. Vaccines have been developed against viral, bacterial, parasitic and allergenic antigens for human as well as animal use using plant expression systems. Stable integration of transgene into the nuclear or chloroplast genome in many plants (e.g. tobacco, tomato, potato, papaya, carrot) for the production of subunit vaccines have been reported, effective expression has also been achieved by transient expression. Many plant produced recombinant proteins have shown immunogenicity, several have been shown to work effectively in animal models. This review tries to give an update of plant produced recombinant proteins, the future and limitations.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Advanced Techniques in Biology & Medicine.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvanced Techniques in Biology & Medicine
- SubjectBiology
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Mathangi Ganapathy”

